NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-029526 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 29, 2026 |
| Document Date | Jan 27, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
217,284
Total Value
$3,125,324.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Jan 27, 2026 | Exercise/Conversion | 39,816 | $10.90 | $433,994.40 | 64,169 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 27, 2026 | Sale | 39,816 | $32.62 | $1,298,797.92 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 28, 2026 | Exercise/Conversion | 32,612 | $10.90 | $355,470.80 | 56,965 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 28, 2026 | Sale | 32,612 | $31.80 | $1,037,061.60 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 39,816 | $0.00 | $0.00 | 105,746 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 32,612 | $0.00 | $0.00 | 73,134 | Direct | โ | View Details |